Detecting Waning Serological Response with Commercial Immunoassays: 18-Month Longitudinal Follow-up of Anti-SARS-CoV-2 Nucleocapsid Antibodies

Detecting Waning Serological Response with Commercial Immunoassays: 18-Month Longitudinal Follow-up of Anti-SARS-CoV-2 Nucleocapsid Antibodies

ABSTRACT Past severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is an important determinant of protection from reinfection and of postvaccine immune responses. Herein, we conducted a follow-up analysis of health care workers previously infected with coronavirus disease 2019 (COV...

Full description

Bibliographic Details
Main Authors: Yu Nakagama, Yuko Komase, Natsuko Kaku, Yuko Nitahara, Evariste Tshibangu-Kabamba, Tomoyo Tominaga, Hiroko Tanaka, Tomoaki Yokoya, Minako Hosokawa, Yasutoshi Kido
Format: Article
Language:English
Published: American Society for Microbiology 2022-08-01
Series:Microbiology Spectrum
Subjects:
COVID-19
SARS-CoV-2
waning antibody
serological kinetics
Online Access:https://journals.asm.org/doi/10.1128/spectrum.00986-22

Internet

https://journals.asm.org/doi/10.1128/spectrum.00986-22

Similar Items